Laura Johnson Bollier is named as a lobbyist on federal disclosure filings for 56 clients through Brownstein Hyatt Farber Schreck, LLP. The most recent filing naming them posted in April 2024. Issues reported include Health Issues, Education, Medicare/Medicaid and Taxation/Internal Revenue Code.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| NATIONAL COLLEGIATE ATHLETIC ASSOCIATION | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2023 | Sports/Athletics |
| THE EARLY CARE AND EDUCATION CONSORTIUM | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Taxation/Internal Revenue Code, Education |
| CHEGG, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q4 2023 | Education |
| ARDENT HEALTH SERVICES | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2023 | Medicare/Medicaid, Health Issues |
| NATIONAL RESILIENCE, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2023 | Manufacturing, Health Issues, Economics/Economic Development |
| LIFEPOINT HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2023 | Health Issues |
| JOHNSON & JOHNSON SERVICES, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2023 | Health Issues |
| WALGREEN CO. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2023 | Medicare/Medicaid, Health Issues, Pharmacy |
| INVEST IN EDUCATION COALITION | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2023 | Education |
| COLORADO STATE UNIVERSITY | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2023 | Education |
| ROMARK GLOBAL PHARMA, LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2023 | Pharmacy |
| APOLLO GLOBAL MANAGEMENT | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Financial Institutions/Investments/Securities, Government Issues |
| CAREDX, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Health Issues |
| MONOGRAM HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Health Issues |
| ABBVIE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Health Issues, Taxation/Internal Revenue Code |
| NOVARTIS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Health Issues |
| THE FEDERATION OF STATE MEDICAL BOARDS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Health Issues |
| NATIONAL HEAD START ASSOCIATION | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Education |
| KINDERCARE EDUCATION, LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Taxation/Internal Revenue Code, Agriculture, Education |
| SPARK THERAPEUTICS, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Health Issues |
| ENOVIS CORPORATION | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Health Issues |
| TENET BUSINESS SERVICES CORPORATION | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Health Issues |
| TEXAS CHILDREN'S HOSPITAL | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Health Issues |
| CENTENE CORPORATION | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Health Issues |
| UNIVERSITY OF PHOENIX | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Education |
| VALLEY CHILDREN'S HEALTHCARE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Health Issues, Education |
| KNOA PHARMA | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Health Issues |
| CHSPSC, LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Health Issues |
| CENGAGE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2023 | Education |
| JACOBS ENGINEERING GROUP INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2023 | Health Issues |
| EMERGENCY NURSES ASSOCIATION | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2023 | Health Issues |
| CEPHEID | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2023 | Medicare/Medicaid, Health Issues |
| THE ORTHOFORUM | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2023 | Medicare/Medicaid |
| INDEELIFT | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q4 2022 | Health Issues |
| CONNOLLY ENTERPRISES LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q4 2022 | Health Issues |
| NMAC (ON BEHALF OF THE HIV/STD PARTNERSHIP) | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2022 | Medical/Disease Research/Clinical Labs |
| AVENTIV TECHNOLOGIES, LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2022 | Telecommunications |
| BECKMAN COULTER DIAGNOSTICS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2021 | Health Issues |
| ANTHEM, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2022 | Health Issues |
| HEMOCUE AMERICA | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2022 | Health Issues |
| BAXTER HEALTHCARE CORPORATION | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2022 | Medicare/Medicaid, Health Issues |
| SOUTHEAST ALASKA REGIONAL HEALTH CONSORTIUM | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2022 | Real Estate/Land Use/Conservation, Health Issues, Indian/Native American Affairs |
| ADITXT INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2022 | Health Issues |
| AIPHARMA GLOBAL HOLDINGS LIMITED | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2022 | Health Issues, Pharmacy |
| PATHEMAGX | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q4 2021 | Health Issues |
| ATRIUM HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2021 | Health Issues, Labor Issues/Antitrust/Workplace |
| EXHIBITIONS & CONFERENCES ALLIANCE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2021 | Travel/Tourism, Arts/Entertainment |
| CROWELL & MORING LLP OBO COGITATIVO, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2021 | Science/Technology, Health Issues |
| AKTIV PHARMA GROUP | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2021 | Pharmacy |
| TRIBAL SOLUTIONS MEDICAL | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2021 | Health Issues, Indian/Native American Affairs |
| FREEWILL NETWORKS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2021 | Health Issues |
| ENVISION HEALTHCARE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2021 | Health Issues |
| ADVAMED | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2021 | Taxation/Internal Revenue Code |
| PARAGON BIOSCIENCES, LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q4 2020 | Pharmacy |
| IGT SOLUTIONS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q4 2020 | Health Issues |
| AMGEN USA INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q4 2020 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2023 | 33 | 1 |
| 2022 | 41 | 1 |
| 2021 | 41 | 1 |
| 2020 | 34 | 1 |
| Year | Items | Total |
|---|---|---|
| 2023 | 1 | $250 |
| 2022 | 8 | $2K |
| 2021 | 11 | $3K |
| 2020 | 1 | $250 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Laura Johnson Bollier. See the Capitol Clarity rankings and method.